This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap

First Page		Document Content
Date: 2016-08-18 19:09:23 Diabetes Peptide hormones Recombinant proteins Eli Lilly and Company RTT Insulin aspart Insulin Diabetes management Diabetes mellitus type 1 Glycated hemoglobin Hyperglycemia Insulin degludec		This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap Add to Reading List Source URL: www.novonordisk.ca Download Document from Source Website File Size: 213,78 KB Share Document on Facebook

	Microsoft Word - Executive summary YDRdoc DocID: 1rp1J - View Document
	Dear Second Grade Parent, Our son Alexander has Type 1 Diabetes. We have explained this condition to your child, Alex’s classmate, so that he/she may have a better understanding of what they may occasionally witness. W DocID: 1rnZI - View Document
	1039 RECENT ADVANCES IN ENDOCRINOLOGY Diabetes and balanoposthitis Sanjay Kalra,1 Aastha Chawla2 DocID: 1rhvJ - View Document
	A New Year’s Update from the T1D Exchange! We would like to thank-‐you for joining the T1D Exchange! We now have over DocID: 1r7n0 - View Document
	1026 CASE REPORT Type 1 diabetes mellitus presenting with diabetic ketoacidosis (DKA) in a neonate Fareed Ahmed, Ghazala Kazi, Waqas Khan DocID: 1qQm6 - View Document